Sort   by:  
 Page size 
UnknownAnticancer Platinum Drugs Update.
Not available
S-EPMC8615753 | biostudies-literature
UnknownRegulation Mechanisms of Expression and Function of Organic Cation Transporter 1.
Not available
S-EPMC7959823 | biostudies-literature
UnknownMembrane transporters as mediators of Cisplatin effects and side effects.
Not available
S-EPMC3820462 | biostudies-literature
UnknownHuman OCT2 variant c.808G>T confers protection effect against cisplatin-induced ototoxicity.
Not available
S-EPMC4865798 | biostudies-literature
UnknownExacerbation of Cisplatin Cellular Toxicity by Regulation of the Human Organic Cation Transporter 2 through Angiotensin II.
Not available
S-EPMC9779897 | biostudies-literature
UnknownThe organic cation transporters 1 and 2 mediate ethanolamine cellular efflux and control systemic phosphatidylethanolamine level.
Not available
S-EPMC12719660 | biostudies-literature
UnknownRegulation of Transporters for Organic Cations by High Glucose.
Not available
S-EPMC10531077 | biostudies-literature
UnknownImportance of the novel organic cation transporter 1 for tyrosine kinase inhibition by saracatinib in rheumatoid arthritis synovial fibroblasts.
Not available
S-EPMC5430895 | biostudies-literature
Unknown<i>Ex vivo</i> perfusion model of mouse liver and its application to analyze the effects of OCT1 deficiency.
Not available
S-EPMC12660287 | biostudies-literature
UnknownOxaliplatin-induced neurotoxicity is dependent on the organic cation transporter OCT2.
Not available
S-EPMC3704038 | biostudies-literature
Sort   by:  
 Page size